Literature DB >> 5149092

Metformin administration in hyperlipidemic states.

A Gustafson, P Björntorp, M Fahlén.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5149092     DOI: 10.1111/j.0954-6820.1971.tb07464.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


× No keyword cloud information.
  6 in total

Review 1.  A risk-benefit assessment of metformin in type 2 diabetes mellitus.

Authors:  H C Howlett; C J Bailey
Journal:  Drug Saf       Date:  1999-06       Impact factor: 5.606

2.  The direct effects of metformin on platelet function in vitro.

Authors:  R De Caterina; P Marchetti; W Bernini; R Giannarelli; D Giannessi; R Navalesi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

3.  Effect of plasma metformin concentrations on serum lipid levels in type II diabetic patients.

Authors:  P Marchetti; L Benzi; M Cerri; P Cecchetti; R Giannarelli; M Giannecchini; G Di Cianni; R Cristofani; R Miccoli; A Bertolotto
Journal:  Acta Diabetol Lat       Date:  1988 Jan-Mar

4.  [Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].

Authors:  P Weisweiler; P Schwandt
Journal:  Klin Wochenschr       Date:  1976-03-15

5.  Pharmacokinetics of metformin after intravenous and oral administration to man.

Authors:  P J Pentikäinen; P J Neuvonen; A Penttilä
Journal:  Eur J Clin Pharmacol       Date:  1979-09       Impact factor: 2.953

Review 6.  Treatment of non-insulin-dependent diabetes mellitus and its complications. A state of the art review.

Authors:  A Ilarde; M Tuck
Journal:  Drugs Aging       Date:  1994-06       Impact factor: 3.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.